UBS Group AG - GEMINI THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 52 filers reported holding GEMINI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of GEMINI THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$102,000
-56.4%
61,900
-55.3%
0.00%–
Q2 2022$234,000
+4580.0%
138,470
+10527.0%
0.00%–
Q3 2021$5,000
+66.7%
1,303
+208.8%
0.00%–
Q2 2021$3,000
-78.6%
422
-58.8%
0.00%–
Q1 2021$14,000–1,024–0.00%–
 Download
Other shareholders
GEMINI THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Running Point Capital Advisors, LLC 10,000$13,5000.01%
Ulland Investment Advisors, LLC 0$00.00%
View complete list of GEMINI THERAPEUTICS INC shareholders